Total submissions: 15
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000182467 | SCV000234812 | benign | not specified | 2014-06-11 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Labcorp Genetics |
RCV001000697 | SCV000285783 | benign | Aortic aneurysm, familial thoracic 4 | 2024-01-26 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV000182467 | SCV000306175 | likely benign | not specified | criteria provided, single submitter | clinical testing | ||
Ambry Genetics | RCV000246269 | SCV000319459 | likely benign | Familial thoracic aortic aneurysm and aortic dissection | 2015-02-27 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Illumina Laboratory Services, |
RCV001000697 | SCV000395358 | uncertain significance | Aortic aneurysm, familial thoracic 4 | 2018-01-12 | criteria provided, single submitter | clinical testing | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease. |
Center for Human Genetics, |
RCV000680556 | SCV000807969 | likely benign | Connective tissue disorder | 2018-06-01 | criteria provided, single submitter | clinical testing | |
Color Diagnostics, |
RCV000246269 | SCV000913779 | likely benign | Familial thoracic aortic aneurysm and aortic dissection | 2018-07-20 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000182467 | SCV000917830 | benign | not specified | 2018-01-08 | criteria provided, single submitter | clinical testing | Variant summary: The MYH11 c.3052T>C (p.Leu1018Leu) variant involves the alteration of a non-conserved nucleotide, resulting in a synonymous change. One in silico tool predicts a damaging outcome for this variant. 5/5 splice prediction tools predict no significant impact on normal splicing. ESE finder predicts that this variant may affect multiple ESE sites. However, these predictions have yet to be confirmed by functional studies. This variant was found in 121/277210 control chromosomes at a frequency of 0.0004365, which is approximately 349 times the estimated maximal expected allele frequency of a pathogenic MYH11 variant (0.0000013), suggesting this variant is likely a benign polymorphism. In addition, multiple clinical diagnostic laboratories/reputable databases classified this variant as benign/likely benign. Taken together, this variant is classified as benign. |
Ce |
RCV000228093 | SCV001150831 | likely benign | not provided | 2024-05-01 | criteria provided, single submitter | clinical testing | MYH11: BP4, BP7 |
ARUP Laboratories, |
RCV000228093 | SCV001157736 | likely benign | not provided | 2023-09-25 | criteria provided, single submitter | clinical testing | |
CHEO Genetics Diagnostic Laboratory, |
RCV000246269 | SCV002042930 | likely benign | Familial thoracic aortic aneurysm and aortic dissection | 2020-10-22 | criteria provided, single submitter | clinical testing | |
All of Us Research Program, |
RCV000246269 | SCV004821371 | likely benign | Familial thoracic aortic aneurysm and aortic dissection | 2024-02-05 | criteria provided, single submitter | clinical testing | |
Genome Diagnostics Laboratory, |
RCV000228093 | SCV001807084 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV000228093 | SCV001931941 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000228093 | SCV001968122 | likely benign | not provided | no assertion criteria provided | clinical testing |